Table 1. Clinical characteristics of HIV-1 patient cohorts.

Patient ID	Treatment history	Years on therapy	Age (years)	CD4 count (cell/µl)	Plasma VL(copies/ml)
Control group (n = 12)	Healthy controls	n.a.	Median (30) range (23–60)	n.t.	n.a.
N01	Naïve	n.a.	46	214	500000
N02	Naïve	n.a.	36	69	226208
N03	Naïve	n.a.	38	198	1163
N04	Naïve	n.a.	33	362	202
N05	Naïve	n.a.	41	350	7000
N06	Naïve	n.a.	42	460	324414
N07	Naïve	n.a.	40	1000	10000
N08	Naïve	n.a.	36	41	100389
N09	Naïve	n.a.	60	957	20497
N10	Naïve	n.a.	33	255	68342
N11	Naïve	n.a.	30	215	14337
N12	Naïve	n.a.	37	451	1480
N13	Naïve	n.a.	47	191	14069
Median (range)	-	-	38 (30–60)	255 (41–1000)	14337 (202–500000)
H01	HAART	5.5	41	500	<50
H02	HAART	4.4	54	390	<50
H03	HAART	5.4	50	1000	<50
H04	HAART	5.6	45	500	<50
H05	HAART	5.9	43	405	<50
H06	HAART	8.3	43	548	<50
H07	HAART	8.7	41	961	<50
H08	HAART	5.8	53	302	<50
H09	HAART	3.9	44	185	<50
H10	HAART	11.6	43	505	<50
H11	HAART	11.6	47	705	<50
H12	HAART	4.0	59	414	<50
Median (range)	-	5.7 (3.9–11.6)	44.5 (41–59)	500 (185–1000)	<50

n.a: not applicable, m: male, f: female, n.t. not tested.